Avantor (NYSE:AVTR – Get Free Report) is scheduled to be releasing its earnings data before the market opens on Friday, October 25th. Analysts expect Avantor to post earnings of $0.25 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.
Avantor (NYSE:AVTR – Get Free Report) last announced its quarterly earnings results on Friday, July 26th. The company reported $0.25 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The company had revenue of $1.70 billion during the quarter, compared to analysts’ expectations of $1.70 billion. On average, analysts expect Avantor to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.
Avantor Stock Down 0.8 %
Shares of AVTR opened at $23.72 on Thursday. Avantor has a 52 week low of $16.63 and a 52 week high of $28.00. The stock has a market capitalization of $16.11 billion, a price-to-earnings ratio of 60.82, a PEG ratio of 2.93 and a beta of 1.33. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. The stock has a fifty day moving average of $25.59 and a 200-day moving average of $24.30.
Analyst Ratings Changes
Read Our Latest Analysis on Avantor
Insiders Place Their Bets
In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction dated Thursday, September 5th. The stock was sold at an average price of $25.06, for a total transaction of $88,336.50. Following the completion of the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.50% of the company’s stock.
Avantor Company Profile
Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.
Featured Articles
- Five stocks we like better than Avantor
- What Are Dividends? Buy the Best Dividend Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- 3 REITs to Buy and Hold for the Long Term
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- Options Trading – Understanding Strike Price
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.